Metformin showed promise for improving the overall survival rate of patients with melanoma; however, this result may be an indirect consequence of the drug. “Based on the progress of research on new ...

Before the explosive popularity of GLP-1 weight loss drugs, another "wonder drug," metformin, has been at work lowering blood sugar levels for patients with Type 2 diabetes for decades, but scientists ...

Recent research from Stanford University and Harvard Medical School (both MA, USA) has used a combination of mouse models, human blood samples and statistical analysis to reveal the mechanism behind ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

With the two active components, sitagliptin and metformin, Janumet has a comprehensive mechanism of action that targets all three key defects of T2DM for improved glycemic control: diminished insulin ...

Researchers at Université de Montréal’s affiliated hospital research centre, the CRCHUM, say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.

A recent study published in the journal Nature Metabolism showed that metformin treatment significantly increases blood levels of N-lactoyl phenylalanine (Lac-Phe), an appetite-suppressing metabolite.

Metformin, an oral medication used to treat type 2 diabetes, is often prescribed off-label for weight loss. It helps to control blood sugar by reducing both the amount of glucose produced by the liver ...

A hospital in Thailand created a quick-action dialysis protocol for patients with metformin-associated lactic acidosis, a dangerous reaction to a common diabetes drug. The program sharply reduced ...

Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.